The first recombinant DNA pharmaceutical product approved for human use was:
BiologyBiotechnology and its Applications · Recombinant DNA Technology in Medicine
- A. Human Growth Hormone
- B. Recombinant Human Insulin
- C. Erythropoietin
- D. Tissue Plasminogen Activator
Show answer & explanation
Answer: (B) Recombinant Human Insulin
Explanation
Recombinant human insulin (Humulin) was the first recombinant DNA-derived pharmaceutical product approved for human therapeutic use. It was produced using E. coli by Eli Lilly in 1982, replacing insulin extracted from pig or cow pancreas.
Practise every Biotechnology and its Applications question with a timer
Chapter tests, full NEET mocks, your score and weak topics — 70,000+ questions on YNeet.
Start free for 30 daysNo payment, no card. Sign up in 30 seconds.
For Class 11, 12 and droppers, see what the YNeet NEET online course includes.
More Biotechnology and its Applications questions
- RNA interference (RNAi) technology was used to develop nematode-resistant tobacco plants. Which of the…
- The Bt toxin is a protoxin in bacteria but becomes active in the insect gut. What condition in the insect…
- The first clinical gene therapy trial was performed in 1990 on a 4-year-old girl suffering from which disease?
- In ELISA (Enzyme-Linked Immunosorbent Assay), which of the following pairs correctly describes the principle…
- Rosie, the transgenic cow, produced milk with human alpha-lactalbumin. What was the primary reason this milk…
- Which of the following best defines 'biopiracy' in the context of biotechnology?
- Which of the following statements about recombinant human insulin production is INCORRECT?
- Bt toxin produced by Bacillus thuringiensis is encoded by which gene?